2021
DOI: 10.1590/1678-4685-gmb-2021-0149
|View full text |Cite
|
Sign up to set email alerts
|

NDUFV1 mutations in complex I deficiency: Case reports and review of symptoms

Abstract: Mitochondrial complex I (CI) deficiency is the most common oxidative phosphorylation disorder described. It shows a wide range of phenotypes with poor correlation within genotypes. Herein we expand the clinics and genetics of CI deficiency in the brazilian population by reporting three patients with pathogenic (c.640G>A, c.1268C>T, c.1207dupG) and likely pathogenic (c.766C>T) variants in the NDUFV1 gene. We show the mutation c.766C>T associated with a childhood onset phenotype of hypoton… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 32 publications
0
3
0
Order By: Relevance
“…The PC and NDUFV1 are genes present at 11q13.2, which have been associated with pyruvate carboxylase deficiency syndrome (PCDS; OMIM #266150) and mitochondrial complex I deficiency nuclear type 4 (MC1DN4; OMIM #618225), respectively. Both syndromes are associated with loss of function mutations, which promote a mitochondrial metabolism dysfunction [Mhanni et al, 2021;Zanette et al, 2021]. We detected the overexpression of PC and NDUFV1 in different tissues of our patient, who disclosed some overlapping clinical features with PCDS and MC1DN4 including intellectual disability, developmental delay, and corpus callosum dysgenesis (Table 1; Fig.…”
Section: Discussionmentioning
confidence: 73%
“…The PC and NDUFV1 are genes present at 11q13.2, which have been associated with pyruvate carboxylase deficiency syndrome (PCDS; OMIM #266150) and mitochondrial complex I deficiency nuclear type 4 (MC1DN4; OMIM #618225), respectively. Both syndromes are associated with loss of function mutations, which promote a mitochondrial metabolism dysfunction [Mhanni et al, 2021;Zanette et al, 2021]. We detected the overexpression of PC and NDUFV1 in different tissues of our patient, who disclosed some overlapping clinical features with PCDS and MC1DN4 including intellectual disability, developmental delay, and corpus callosum dysgenesis (Table 1; Fig.…”
Section: Discussionmentioning
confidence: 73%
“…The brain tissue models are prevalent with three TFs, ETS Proto-Oncogene 1, Transcription Factor (ETS1), Forkhead box protein O1 (FOXO1) and PR/SET Domain 14 (PRDM14), each appearing in almost half of the brain tissues. These TFs are also associated with some of the same neurological conditions associated with regulation of their modeled hit gene, NDUFV1: ETS1 is associated with complex I deficiency [ 42 , 46 ], expression levels of FOXO1 are decreased in acute schizophrenia [ 47 ] and increased in AD [ 48 ]. Finally, PRDM14 has key role in modulating specific regulatory functions in schizophrenia [ 49 ], suggesting a possible mechanism for these three TFs to affect these conditions through NDUFV1.…”
Section: Resultsmentioning
confidence: 99%
“…8), and is important for supporting overall respiration and mitochondrial integrity (Fig. 4), could implicate CISD3 in some of the different conditions described above, associated with NDUFV2 deficiency, as well as in additional mitochondrial complex I deficiencies, such as fatal neonatal lactic acidosis, leukoencephalopathy, hepatopathy, cardiomyopathy, childhood-onset mitochondrial encephalomyopathy, and stroke-like episodes [54][55][56] . The potential involvement of CISD3 in these and other presentations associated with mitochondrial/Complex I function should be explored in future studies, as CISD3 could become a molecular marker for some of these conditions.…”
Section: Discussionmentioning
confidence: 99%